FLUENT Corp. reported financial and operating results for Q3 2025, with revenue at $26.0 million, a slight decline from the previous year due to margin pressures. Adjusted EBITDA was $2.8 million, mainly impacted by lower revenue and margins. The company took actions to address challenges and optimize operations for long-term value creation.

Operational highlights include the opening of new dispensaries in Florida, completion of the first harvests at the Rosa indoor production facility, and the nearing launch of premium SKUs from Connected and Alien Labs in New York. FLUENT anticipates improved distillate yields contributing to margin recovery in Q4 2025.

Recent regulatory changes in the US federal government are expected to impact the cannabis market, particularly in Florida and Texas. FLUENT anticipates these changes may lead to a more stable, regulated market environment that supports the company’s focus on improving margins and operational efficiency.

FLUENT Corp.’s consolidated financial statements for Q3 2025 show a net loss of $13.6 million, with EBITDA at $1.7 million for the quarter. For the nine months ended September 30, 2025, the company reported a net loss of $32 million and adjusted EBITDA of $10.1 million.

The company’s strategic focus is on operational excellence, margin expansion, and long-term value creation. FLUENT operates in Florida, New York, Pennsylvania, and Texas, with a total of 37 retail locations and 8 production facilities across key markets. For more information, visit www.getFLUENT.com.

Read more at GlobeNewswire: FLUENT Reports Third Quarter 2025 Results